Dr Reddy's Laboratories Ltd has received permission to sell Quetiapine in New Zealand from Pharmac, the drug-funding agency of New Zealand Government. Quetiapine is a drug indicated for treatment of manic and depressive dimensions of bipolar disorder. The drug would be introduced in New Zealand market from October 1 and Pharmac would fully fund (completely reimburse the expenses incurred) the drug made Dr Reddy’s.

 

Dr Reddy's would be the third player selling the drug, apart from the two existing suppliers including AstraZeneca. During last financial year, the company earned $7 million revenue from New Zealand. Dr Reddy's was actively working in New Zealand market and had plans to increase its presence in the coming months.

crackcrack

Dr. Reddys Lab Share Price

1276.55 -0.45 (-0.04%)
05-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1520.55
Zydus Lifesciences 933.10
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×